Palantir Technologies (NASDAQ:PLTR) ended the trading week at $122.92, reflecting a decline of 7.1% from the prior Friday. The drop outpaced the broader market, as the Nasdaq Composite fell 2.1% over the same period. The divergence highlights growing concerns about the company's elevated valuation ahead of its second-quarter earnings report, scheduled for release after the market close on Monday, August 3.
Valuation Remains Elevated
Despite the recent pullback, Palantir continues to trade at a high multiple. Based on the diluted share count from the first quarter, the company's equity is valued at approximately $316 billion. This represents roughly 41.3 times the midpoint of its projected revenue for 2026. Shares are currently trading 40.8% below their 52-week high.
The company reported first-quarter revenue of $1.633 billion and set its second-quarter guidance midpoint at $1.799 billion. To meet the implied full-year forecast, Palantir would need to generate $4.224 billion in the second half of 2026, which translates to average quarterly revenue of $2.112 billion in the third and fourth quarters — a 17.4% increase from the second-quarter midpoint. These estimates remain provisional.
Peer Comparison and Weekly Performance
Among its peers, Palantir posted the steepest weekly decline. Salesforce (NYSE:CRM) fell 4.2% to $163.66, while Snowflake (NYSE:SNOW) slipped 0.3% to $268.06. The bulk of Palantir's losses occurred on Wednesday, when shares dropped 6.1%, marking the sharpest single-day decline of the week.
The sell-off was partly attributed to increased regulatory scrutiny in the United Kingdom. According to the Financial Times, NHS England appended disclaimers to positive results regarding Palantir's health platform, and a UK statistics review indicated the data could not demonstrate a causal relationship. This development added to the valuation pressure on the stock.
Strong Fundamentals but Growth Questions Persist
Despite the market concerns, Palantir's core business remains robust. First-quarter revenue surged 85% year over year, while gross margin climbed to 87% from 80% in the prior year period. U.S. commercial revenue jumped 133% to $595 million, and revenue from the U.S. government increased 84% to $687 million.
Chief Executive Alex Karp commented in May, "Momentum surged as we grew 85% last quarter." The company's management raised its 2026 revenue outlook to a range of $7.650 billion to $7.662 billion, according to SEC filings.
However, analysts remain divided on the sustainability of this growth. Brent Thill, an analyst at Jefferies Financial Group (NYSE:JEF), questioned "whether growth can keep accelerating off a much larger base." Thill holds a sell rating on Palantir with a $70 price target. In contrast, Citigroup (NYSE:C) analyst Tyler Radke reiterated a buy rating with a $200 price target.
Upcoming Catalysts
Investors will have several key events to watch next week. The Federal Reserve holds its policy meeting on July 28-29, and major tech earnings are due: Microsoft (NASDAQ:MSFT) reports on Wednesday, followed by Amazon (NASDAQ:AMZN) on Thursday. Palantir's second-quarter results are scheduled for Monday, August 3, with a webcast at 5 p.m. ET.
The market will scrutinize whether Palantir can deliver revenue within its $1.797 billion to $1.801 billion forecast and whether any upward revision to the annual guidance confirms the implied second-half acceleration. Risks include delays in contract awards, ongoing UK regulatory review, and rising interest rates, which could further pressure the stock's valuation. Conversely, accelerated U.S. expansion or more optimistic guidance could trigger a rebound.
